Suchergebnisse - "Baverel, Paul G"

PubPharm (21)

1

Exposure driven dose escalation design with overdose control : Concept and first real life experience in an oncology phase I trial

enthalten in: Contemporary clinical trials communications | 2022

von Micallef, S. | Sostelly, A. | Zhu, J. | +2

2

Step-by-step comparison of ordinary differential equation and agent-based approaches to pharmacokinetic-pharmacodynamic models

enthalten in: CPT: pharmacometrics & systems pharmacology | 2022

von Truong, V. | Baverel, P. | Lythe, G. | +3

3

Step‐by‐step comparison of ordinary differential equation and agent‐based approaches to pharmacokinetic‐pharmacodynamic models

enthalten in: CPT: Pharmacometrics & Systems Pharmacology | 2022

von Truong, V. | Baverel, P. | Lythe, G. | +3

4

Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy : A Free Assay Disguised as Total

enthalten in: Pharmaceutics | 2021

von Hood, J. | González-García, I. | White, N. | +4

5

Association of circulating protein biomarkers with clinical outcomes of durvalumab in head and neck squamous cell carcinoma

enthalten in: Oncoimmunology | 2021

von Arends, R. | Guo, X. | Baverel, P. | +5

6

Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapy

enthalten in: CPT: pharmacometrics & systems pharmacology | 2021

von González-García, I. | Pierre, V. | Dubois, V. | +4

7

Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapy

enthalten in: CPT: Pharmacometrics & Systems Pharmacology | 2021

von González‐García, I. | Pierre, V. | Dubois, V. | +4

8

Dose-Exposure-Response Relationship of the Investigational Anti-Interleukin-13 Monoclonal Antibody Tralokinumab in Patients With Severe, Uncontrolled Asthma

enthalten in: Clinical pharmacology and therapeutics | 2018

von Baverel, P. | White, N. | Vicini, P. | +2

9

Population Modeling of Tumor Kinetics and Overall Survival to Identify Prognostic and Predictive Biomarkers of Efficacy for Durvalumab in Patients With Urothelial Carcinoma

enthalten in: Clinical pharmacology and therapeutics | 2018

von Zheng, Y. | Narwal, R. | Jin, C. | +8

10

Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status

enthalten in: Clinical pharmacology and therapeutics | 2018

von Baverel, P. | Dubois, V. | Jin, C. | +10